ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print December 19, 2007
Eur Respir J 2007, doi:10.1183/09031936.00113307
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
31/4/847    most recent
09031936.00113307v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiménez Castro, D.
Right arrow Articles by D. Yusen, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiménez Castro, D.
Right arrow Articles by D. Yusen, R.


ORIGINAL ARTICLE

Troponin I and risk stratification of patients with acute non massive pulmonary embolism

D. Jiménez Castro 1*, G. Díaz 1, J. Molina 1, D. Martí 2, J. Del Rey 3, S. García-Rull 1, C. Escobar 2, R. Vidal 1, A. Sueiro 1, R. D. Yusen 4

1 Respiratory Dept, Ramón y Cajal Hospital, Madrid, Spain
2 Cardiology Dept, Ramón y Cajal Hospital, Madrid, Spain
3 Clinical Biochemistry Dept, Ramón y Cajal Hospital, Madrid, Spain
4 Divisions of Pulmonary and Critical Care Medicine and General Medical Sciences, Washington University School of Medicine, St. Louis, Missouri, USA

* To whom correspondence should be addressed. E-mail: djc_69_98{at}yahoo.com.


   Abstract

Assessment of risk and appropriate treatment of patients with acute pulmonary embolism (PE) remains a challenge.

We prospectively assessed the prognostic performance of troponin I (cTnI) in predicting 30-day all-cause mortality in consecutive hemodynamically stable patients with PE.

The study included 318 hemodynamically stable patients with PE. During the 30-day study period, 23 patients (7%) died. cTnI was elevated (≥0.1 ng mL-1) in 102 patients (32%). Age >65 years, systolic blood pressure <120 mm Hg, and severity of illness assessed using the Pulmonary Embolism Severity Index (PESI) were significantly associated with an increased risk for mortality, but no significant association was found between elevation of cTnI and 30-day mortality in the logistic regression analysis. When only fatal PE was considered, multivariate analysis showed that severity of illness using the PESI, and an elevated cTnI (OR, 3.7; 95% CI, 1.1–12.8, P=0.03) were associated with a significant increase in the risk for death. The negative predictive value of a negative cTnI for mortality was 93% (95% CI: 90–97%).

In a series of hemodynamically stable patients with acute PE, cTnI was not an independent predictor of 30-day all-cause mortality, though it predicted fatal PE.

Keywords:  Prognosis, pulmonary embolism, troponin




This article has been cited by other articles:


Home page
ChestHome page
D. Jimenez, F. Uresandi, R. Otero, J. L. Lobo, M. Monreal, D. Marti, J. Zamora, A. Muriel, D. Aujesky, and R. D. Yusen
Troponin-Based Risk Stratification of Patients With Acute Nonmassive Pulmonary Embolism: Systematic Review and Metaanalysis
Chest, October 1, 2009; 136(4): 974 - 982.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
O. Sanchez, B. Planquette, and G. Meyer
Update on acute pulmonary embolism
Eur. Respir. Rev., September 1, 2009; 18(113): 137 - 147.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the European Respiratory Society.